Goodwin Procter’s Technology and Life Sciences Practice advised on 15 initial public offerings for technology and life sciences companies through the third quarter of 2013. The offerings included eight issuer side representations and seven underwriter representations. Goodwin is consistently ranked among the most active legal advisors for IPOs in the industry. View the full ranking of law firms advising the issuer in IPOs through Q3.
Notable issuer side representations for Goodwin through Q3 include:
- Foundation Medicine (Nasdaq: FMI)
- bluebird bio (Nasdaq: BLUE)
- Control4 Corporation (Nasdaq: CTRL)
- BioAmber (NYSE: BIOA)
- Xoom Corporation (Nasdaq: XOOM)
Read more about Goodwin’s Technology and Life Sciences Practice.